An Australian stem cell and regenerative medicine company

November 11, 2022

US patent for Cynata’s novel stem cell tech

Cynata has received a Notice of Allowance from the United States Patent and Trademark Office for a patent application covering its proprietary Cymerus™ mesenchymal stem cell platform technology. This is a very important achievement in a key commercial jurisdiction for Cynata – the US. 

Learn More